Advanced search
Publication Cover
International Medical Case Reports Journal Volume 12, 2019 - Issue
Submit an article Journal homepage
89
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients

Christoforos Kosmidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Georgios Koimtzis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Dimitrios Giannakidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Nikos Tteralli1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Stylianos Mantalovas1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Alexandros Tsakalidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Konstantina Tsopouridou1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Stefanos Atmatzidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Lazaros Liavas1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
&
Paul Zarogoulidis2 Department of Pharmacology and Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece, [email protected]Correspondence[email protected]
 show all
Pages 15-20 | Published online: 11 Jan 2019

References

  • ZaricBStojsicVCarapicVRadial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesionsJ Cancer20167171326722354
  • ZarogoulidisPHuangHBaiCEndobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case seriesRespir Med Case Rep20172218719628879075
  • TsoulosNPapadopoulouEMetaxa-MariatouVTumor molecular profiling of NSCLC patients using next generation sequencingOncol Rep20173863419342929130105
  • CetinBBilgetekinİOzetACurrent uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?Curr Probl Cancer Epub201884
  • RoundsAKolesarJNivolumab for second-line treatment of metastatic squamous non-small-cell lung cancerAm J Health Syst Pharm201572211851185526490818
  • ZarogoulidisPRaptiASardeliCRe-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case seriesRespir Med Case Rep20172117117528616379
  • DahlEKlotenVLiquid biopsy analysis using cell-free DNA (cfDNA): opportunities and limitationsPathologe201536657257826395890
  • WuPWuDLiLChaiYHuangJPD-L1 and survival in solid tumors: a meta-analysisPLoS One2015106e013140326114883
  • HeitzerEUlzPGeiglJBCirculating tumor DNA as a liquid biopsy for cancerClin Chem201561111212325388429
  • ShimadaMTamuraAYokosukaKA successful pembrolizumab treatment case of lung adenocarcinoma after becoming resistant to ALK-TKI treatment due to G1202R mutationRespir Investig2018564365368
  • BassanelliMSioleticSMartiniMHeterogeneity of PD-L1 expression and relationship with biology of NSCLCAnticancer Res20183873789379629970498
  • ZarogoulidisPChinelisPEfthymiouCEGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50Respir Med Case Rep20172271028761805
  • OserMGNiederstMJSequistLVEngelmanJATransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originLancet Oncol2015164e165e17225846096
  • ChenBHuBLiWXueJTransformation from NSCLC to SCLC: when did it happen?Lancet Oncol2015167e309
  • SonodaTNishikawaSSakakibaraREGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancerRespir Med Case Rep201824192129977749
  • LeeSJooJKwakMSohnKChonSRole of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case reportOnco Targets Ther2018113943394730022837
  • TaniguchiYHoriuchiHMorikawaTUsuiKSmall-cell carcinoma transformation of pulmonary adenocarcinoma after osimertinib treatment: a case reportCase Rep Oncol201811232332929928211
  • ShiroyamaTNasuSTanakaATransformation to small cell lung cancer after first-line afatinib treatmentRespir Med Case Rep20182318819029719814
  • YaoYZhuZWuYChaiYHistologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: a case reportMedicine20189718e065029718881
  • HobeikaCRachedGEidRALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment?Per Med201815211111529714122

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.